首页> 外文OA文献 >Nanoscopic core-shell drug carriers made of amphiphilic triblock and star-diblock copolymers.
【2h】

Nanoscopic core-shell drug carriers made of amphiphilic triblock and star-diblock copolymers.

机译:纳米级核壳药物载体由两亲性三嵌段和星形二嵌段共聚物制成。

摘要

The aim of this work was to design injectable nanocarriers for drug delivery based on PCL-PEO amphiphilic block copolymers with linear ABA triblock and 4-armed (BA)(4) star-diblock architectures (A=PEO, B=PCL). The copolymers were obtained by coupling of a monofunctional -COOH end-capped PEO (M(n)=2.0kDa) with linear or 4-armed star-shaped PCL macromers bearing -OH terminal groups and were characterized by (1)H NMR spectroscopy and size exclusion chromatography. DSC and X-ray diffraction experiments showed that separate crystalline phases of PCL and PEO are present in bulk copolymers. Nanoparticles were produced by nanoprecipitation (NP) and by a new melting-sonication procedure (MS) without the use of toxic solvents, and characterized for size, polydispersity, zeta potential and core-shell structure. Nanoparticles were loaded with all-trans-retinoic acid (atRA) as a model drug and their release features assessed. Results demonstrate that both techniques allow the formation of PEO-coated nanoparticles with a hydrodynamic diameter that is larger for nanoparticles prepared by MS. atRA is released from nanoparticles at controlled rates depending on size, loading and, more important, preparation technique, being release rate faster for MS nanoparticles. Some biorelevant properties of the carrier such as complement activation were finally explored to predict their circulation time after intravenous injection. It is demonstrated that nanoparticles prepared by MS do not activate complement and are of great interest for future in vivo applications.
机译:这项工作的目的是基于具有线性ABA三嵌段和4臂(BA)(4)星形二嵌段结构(A = PEO,B = PCL)的PCL-PEO两亲嵌段共聚物设计用于药物输送的可注射纳米载体。该共聚物是通过将单官能团-COOH封端的PEO(M(n)= 2.0kDa)与带有-OH端基的线性或四臂星形PCL大分子单体偶联而获得的,并通过(1)H NMR光谱进行了表征和尺寸排阻色谱。 DSC和X射线衍射实验表明,本体共聚物中存在PCL和PEO的单独的结晶相。纳米颗粒是通过纳米沉淀(NP)和新的熔融超声处理(MS)方法生产的,无需使用有毒溶剂,并且具有尺寸,多分散性,ζ电位和核-壳结构的特征。纳米颗粒负载有全反式维甲酸(atRA)作为模型药物,并评估了其释放特征。结果表明,两种技术均允许形成PEO包覆的纳米颗粒,其流体动力学直径对于MS制备的纳米颗粒而言更大。 atRA是根据大小,负载量以及更重要的是制备技术而以受控的速率从纳米颗粒中释放的,对于MS纳米颗粒而言,其释放速率更快。最后探讨了载体的一些生物相关特性,例如补体激活,以预测静脉注射后的循环时间。已经证明,通过MS制备的纳米粒子不激活补体,并且对于未来的体内应用非常感兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号